Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Already have an account? Login here
Categories // Targeted therapies
A group of researchers from Columbia Engineering and Columbia University Irving Medical Center (CUIMC, NY, USA) have engineered a strain of non-pathogenic bacteria that can colonize solid tumors in mice and safely deliver potent immunotherapies. The findings were recently published in Nature Medicine.
It's completely free